LINDAHL RICHARD S
SEC insider (Form 3/4/5 filer). CIK 0001196632. EVP, Chief Financial Officer at Emergent BioSolutions Inc. (EBS) and 1 other issuer. 18 reported Form 4/5 transactions since Sep 2024; latest on Jun 8, 2026. Located in GAITHERSBURG, MD.
Companies LINDAHL RICHARD S has filed insider reports for
- Emergent BioSolutions Inc. (EBS): Officer, EVP, Chief Financial Officer
- Compass Therapeutics, Inc. (CMPX): Director
LINDAHL RICHARD S
CIK: 0001196632
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Jun 8, 2026EBS
Emergent BioSolutions Inc.
Tax PaymentDirect4K shares at avg. $8.00$32K - Apr 29, 2026EBS
Emergent BioSolutions Inc.
AwardDirect162.7K shares- - Mar 5, 2026EBS
Emergent BioSolutions Inc.
Tax PaymentDirect23.7K shares at avg. $8.44$200K - Mar 3, 2026EBS
Emergent BioSolutions Inc.
AwardDirectEmployee Stock Option (Right to buy)
72.9K shares- - Mar 1, 2026EBS
Emergent BioSolutions Inc.
Tax PaymentDirect683 shares at avg. $8.15$6K - Feb 25, 2026EBS
Emergent BioSolutions Inc.
Expiration (Short)DirectEmployee Stock Option (Right to buy)
20.3K shares- - Feb 6, 2026EBS
Emergent BioSolutions Inc.
Tax PaymentDirect5.6K shares at avg. $10.92$62K - Feb 6, 2026EBS
Emergent BioSolutions Inc.
DispositionDirect46.2K shares at avg. $10.92$504K - Jan 2, 2026CMPX
Compass Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
90K shares- - Oct 15, 2025EBS
Emergent BioSolutions Inc.
Tax PaymentDirect5K shares at avg. $9.60$48K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 8, 2026 |  EBS Emergent BioSolutions Inc. | Tax Payment | 3,964 | $8.00 | $31,712 | Direct |
| Apr 29, 2026 | EBS Emergent BioSolutions Inc. | Award | 162,680 | - | $0 | Direct |
| Mar 5, 2026 | EBS Emergent BioSolutions Inc. | Tax Payment | 23,650 | $8.44 | $199,606 | Direct |
| Mar 3, 2026 | EBS Emergent BioSolutions Inc. | Award Employee Stock Option (Right to buy) | 72,856 | - | - | Direct |
| Mar 1, 2026 | EBS Emergent BioSolutions Inc. | Tax Payment | 683 | $8.15 | $5,566 | Direct |
| Feb 25, 2026 | EBS Emergent BioSolutions Inc. | Expiration (Short) Employee Stock Option (Right to buy) | 20,321 | - | - | Direct |
| Feb 6, 2026 | EBS Emergent BioSolutions Inc. | Tax Payment | 5,642 | $10.92 | $61,611 | Direct |
| Feb 6, 2026 | EBS Emergent BioSolutions Inc. | Disposition | 46,155 | $10.92 | $504,013 | Direct |
| Jan 2, 2026 |  CMPX Compass Therapeutics, Inc. | Award Stock Option (Right to Buy) | 90,000 | - | - | Direct |
| Oct 15, 2025 | EBS Emergent BioSolutions Inc. | Tax Payment | 4,995 | $9.60 | $47,952 | Direct |
1-10 of 18 transactions